This week Bobbi Conner talks with Dr. Julie Kanter about several new therapies being developed to improve treatment for Sickle Cell Disease. Dr. Kanter is an Associate Professor of Hematology/Oncology and Director of Sickle Cell Disease Research at MUSC.
Sickle Cell Research
Facebook Twitter LinkedIn Email
Your browser doesn’t support HTML5 audio